Shenzhen Bioeasy Biotechnology Co. Ltd. Total Liabilities
Shenzhen Bioeasy Biotechnology Co. Ltd. total liabilities. Based on the latest financial reports, Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has total liabilities worth CN¥588.54 Million CNY (≈ $86.12 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 300942 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Total liabilities of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. This chart illustrates how Shenzhen Bioeasy Biotechnology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data.
Shenzhen Bioeasy Biotechnology Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shenzhen Bioeasy Biotechnology Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chongqing Sansheng Building Materials Co Ltd
SHE:002742
|
China | CN¥895.14 Million |
|
Dhani Services Limited
NSE:DHANI
|
India | Rs-28.77 Billion |
|
Frontera Energy Corp
TO:FEC
|
Canada | CA$1.29 Billion |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥711.34 Million |
|
FS Bancorp Inc
NASDAQ:FSBW
|
USA | $2.86 Billion |
|
Morguard Real Estate Investment Trust
TO:MRT-UN
|
Canada | CA$1.31 Billion |
|
ALPHA
KLSE:0303
|
Malaysia | RM58.34 Million |
|
Hamilton Beach Brands Holding Co Class A
NYSE:HBB
|
USA | $194.55 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Shenzhen Bioeasy Biotechnology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Shenzhen Bioeasy Biotechnology Co. Ltd..
Liquidity & Leverage Metrics
Shenzhen Bioeasy Biotechnology Co. Ltd. Total Liabilities Ratios Explained
Shenzhen Bioeasy Biotechnology Co. Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shenzhen Bioeasy Biotechnology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
The table below shows the annual total liabilities of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥616.87 Million ≈ $90.27 Million |
+5.10% |
| 2024-12-31 | CN¥586.92 Million ≈ $85.89 Million |
+15.62% |
| 2023-12-31 | CN¥507.61 Million ≈ $74.28 Million |
+59.75% |
| 2022-12-31 | CN¥317.75 Million ≈ $46.50 Million |
+54.29% |
| 2021-12-31 | CN¥205.94 Million ≈ $30.14 Million |
+98.20% |
| 2020-12-31 | CN¥103.90 Million ≈ $15.20 Million |
+13.75% |
| 2019-12-31 | CN¥91.35 Million ≈ $13.37 Million |
+23.08% |
| 2018-12-31 | CN¥74.22 Million ≈ $10.86 Million |
+25.38% |
| 2017-12-31 | CN¥59.19 Million ≈ $8.66 Million |
-12.73% |
| 2016-12-31 | CN¥67.83 Million ≈ $9.93 Million |
-- |
About Shenzhen Bioeasy Biotechnology Co. Ltd.
Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatm… Read more